Mode
Text Size
Log in / Sign up

Lifetime opioid overdose reported by 55% of pregnant individuals with OUD in buprenorphine treatment studyWhat puts pregnant women with opioid addiction at highest risk for overdose?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider lifetime heroin use, trauma, and financial reliance as factors associated with overdose history in pregnant individuals with OUD.

This descriptive analysis used baseline data from a multisite randomized controlled trial involving 140 treatment-seeking pregnant individuals with opioid use disorder (OUD) receiving buprenorphine treatment. Participants had a mean age of 31.2 years, were 87.1% White, and reported an average of 8.7 years of opioid use. The analysis characterized factors associated with lifetime opioid overdose events.

The main finding was that 55% of participants (77 out of 140) reported at least one lifetime opioid-involved overdose event. The average lifetime number of nonfatal opioid overdose events was 4.8 (SD=12.1). A random forest analysis identified the most important factors associated with lifetime overdose history, in order: lifetime heroin use, trauma exposure, reliance on partners or parents for financial support, depressive symptoms, and lifetime cocaine use. The model's area under the receiver operating characteristic curve was 0.797.

Safety and tolerability data were not reported for this baseline analysis. Key limitations include the descriptive and associative nature of the analysis, which cannot infer causation. The findings are from baseline data of an ongoing RCT, and the relative contributions of factors to peripartum overdose history remain unclear. In practice, these findings highlight potential risk factors to consider during comprehensive assessment of pregnant individuals with OUD, but interventions should be based on established causal evidence.

Imagine being pregnant, in treatment for opioid addiction, and having already survived an overdose. For more than half of the pregnant women in a new study, that's their reality. Researchers looked at 140 pregnant women who were receiving buprenorphine treatment for opioid use disorder. They found that 55%—77 women—reported at least one lifetime opioid overdose, with some having survived many nonfatal events.

The study aimed to understand what factors are linked to this history of overdose. The analysis pointed to a mix of substance use and life circumstances. The most important factors associated with a history of overdose were: a history of using heroin, experiencing trauma, relying on a partner or parents for money, having symptoms of depression, and a history of using cocaine. The model used to identify these links performed reasonably well at distinguishing between those with and without an overdose history.

It's crucial to understand what this study is and isn't. This is a descriptive look at baseline information from a larger clinical trial. The women were, on average, 31 years old, mostly white, and had been using opioids for nearly nine years. The findings show associations—links between certain factors and a history of overdose. They cannot tell us if these factors caused the overdoses, or what might cause a future overdose during pregnancy. The results are a starting point for recognizing complex risks in a vulnerable group.

What this means for you:
For pregnant women in addiction treatment, overdose history is linked to trauma, finances, and depression—not just drug use.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Opioid use disorder (OUD) during pregnancy is a leading contributor to peripartum morbidity and mortality, with overdose deaths rising significantly in recent years. Despite the identification of various factors associated with overdose events, including social, demographic, psychiatric, and neonatal outcomes, the relative contributions of these factors to peripartum overdose history (or lack thereof) remain unclear. Thus, this study aims to characterize factors associated with lifetime opioid-involved overdose events among currently pregnant individuals receiving buprenorphine (BUP) treatment for OUD. METHODS: Treatment-seeking pregnant individuals with an estimated gestational age of 6 to 30 weeks were enrolled in a large multisite randomized controlled trial evaluating 2 BUP formulations for OUD. Participant baseline demographic, substance use, and mental health data were collected using validated measures, and random forest modeling identified key factors associated with lifetime opioid overdose events. RESULTS: The 140 pregnant participants ( = 31.2 years, SD = 4.7; 87.1% White) reported an average of 8.7 years (SD = 5.8) of opioid use, with 92.1% endorsing lifetime prescription opioid use and 82.9% reporting heroin use. The average lifetime number of nonfatal opioid overdose events was 4.8 (SD = 12.1); an overdose was reported by 55% of the sample (n = 77). Random forest analysis (area under the receiver operating characteristic curve = 0.797) incorporating sociodemographic, substance use, and mental health characteristics found that the most important factors associated with lifetime overdose events were, in order, lifetime heroin use, trauma exposure, reliance on partners or parents for financial support, depressive symptoms, and lifetime cocaine use. CONCLUSIONS: These findings underscore the critical need to address substance use, co-occurring mental health, and socioeconomic challenges that are associated with previous opioid overdose. Identifying and targeting key modifiable overdose risk factors can inform the development of tailored interventions to improve outcomes for this population.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.